HANOI, VIETNAM - Media OutReach - 15 August 2022 - On July 20 nd, the Scientific Reports journal (the Nature) officially annouced a break-through research on using LiveSpo NAVAX probiotic spores in nasal spray form to support the treatment of acute respiratory infections in children infected with respiratory syncytial virus (RSV) [1] Respiratory syncytial virus (RSV) is a leading cause.